people worldwide receive diagnosis alzheimer dementias fall blood test developed c n diagnostics st. louis mo. available u.s. routine lab test regulated cms clinical laboratory improvement amendments clia program received ce mark diagnostic medical device european union indicating met safety health environmental protection standards region development blood based test alzheimer disease phenomenal says michelle mielke neuroscientist epidemiologist mayo clinic field thinking long time couple years possibility come fruition c n test called precivityad uses analytic technique known mass spectrometry detect specific types beta amyloid protein fragment pathological hallmark disease beta amyloid proteins accumulate form plaques visible brain scans decades patient